Fig. 5From: Integrated analyzes identify CCT3 as a modulator to shape immunosuppressive tumor microenvironment in lung adenocarcinomaPrognostic prediction evaluation of CCT3 for LUAD. (a) Overall survival of CCT3 low and high LUAD patients showed by K-M survival plot. (b) Distribution of risk score (upper) and its association with survival time CCT3 expression (lower) according to the risk score modelBack to article page